Patents Assigned to Nova Molecular, Inc.
  • Method for determining the prognosis of a patient with a neurological disease
    Patent number: 6251587
    Abstract: The present invention provides a method for the determining the prognosis for a patient diagnosed with a neurological disease. The present invention also provides a method for the identification of human subjects for placement in clinical drug trials of drugs being tested for the treatment of neurological disease and for determining a patient's future disease risk.
    Type: Grant
    Filed: December 16, 1997
    Date of Patent: June 26, 2001
    Assignee: Nova Molecular, Inc.
    Inventors: Pierre Sévigny, Heiko Wiebusch, Keith Schappert